[1] Yamada, S. (1966). Recent aspects of the stereochemistry of Schiff-base-metal complexes. Coord. Chem. Rev., 1(4), 415-437.
[2] Rahman, L. H. A., Khatib, R. M. E., Nassr, L. A. E., Dief, A. M. A. Seleem, A. A. (2014). Design, Characterization, Teratogenicity Testing, Antibacterial, Antifungal and DNA Interaction of Few High Spin Fe (II) Schiff Base Amino Acid Complexes. Spectrochim. Acta A, 117, 366.
[3] Rahman, L. H. A., Khatib, R. M. E., Nassr, L. A. E., Dief, A. M. A., Seleem, A. A. (2014). Metal Based Pharmacologically Active Agents: Synthesis, Structural Characterization, Molecular Modeling, CT-DNA Binding Studies and In Vitro Antimicrobial Screening of Iron (II) Bromosalicylidene Amino Acid Chelates. Spectrochim. Acta A, 117, 366.
[4] Ran, X. G., Wang, L. Y., Lin, Y. C., Hao, Cao, J. D. R. (2010). Syntheses, characterization and biological studies of zinc(II), copper(II) and cobalt(II) complexes with Schiff base ligand derived from 2-hydroxy-1-naphthaldehyde and selenomethionine, Appl. Organometal. Chem., 24, 741.
[5] Shuai, Q., Chen, S., & Gao, S. (2007). Structural and thermal properties of three novel alkaline earth metal coordination polymers based on 5-hydroxyisophthalate ligand. Inorganica Chim. Acta, 360(5), 1381–1387.
[6] Bikas, R., Ghorbanloo, M., Sasani, R., Pantenburg, I., & Meyer, G. (2017). Manganese (II) complexes of hydrazone based NNO-donor ligands and their catalytic activity in the oxidation of olefins. J. Coord. Chem., 70(5), 819-830.
[7] Nikolova-Mladenova B.I., Momekov G.Ts. (2017). Synthesis, characterization and in vitro cytotoxic activity of zinc(II), cobalt(II) and nickel(II) complexes with tridentate ONO Schiff base 3-methoxysalicylaldehyde benzoylhydrazone, Bulg Chem Comm, Special Edition B, 49: 83-88.
[8] Deng, J., Gou, Y., Chen, W., Fu, X., & Deng, H. (2016). The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper (II): Structure, anticancer activity and anticancer mechanism. Bioorg Med Chem., 24(10), 2190-2198.
[9] Gomathi, G., & Gopalakrishnan, R. (2016). A hydrazone Schiff base single crystal (E)-Methyl N′-(3, 4, 5-trimethoxybenzylidene) hydrazine carboxylate: Physicochemical, in vitro investigation of antimicrobial activities and molecular docking with DNA gyrase protein. Mater. Sci. Eng., 64, 133-138.
[10] Harinath, Y., Reddy, D. H. K., Kumar, B. N., Apparao, C., & Seshaiah, K. (2013). Synthesis, spectral characterization and antioxidant activity studies of a bidentate Schiff base, 5-methyl thiophene-2-carboxaldehyde-carbohydrazone and its Cd (II), Cu (II), Ni (II) and Zn (II) complexes. Spectrochim Acta A Mol Biomol Spectrosc., 101, 264-272.
[11] Mahal, A., Abu-El-Halawa, R., Zabin, S. A., Ibrahim, M., Al-Refai, M., & Kaimari, T. (2015). Synthesis, characterization and antifungal activity of some metal complexes derived from quinoxaloylhydrazone. World J. Org. Chem., 3(1), 1-8.
[12] Zubair, H., Azim, S., Ahmad, A., Khan, M. A., Patel, G. K., Singh, S., & Singh, A. P. (2017). Cancer chemoprevention by phytochemicals: Nature’s healing touch. Molecules, 22(3), 395.
[13] Abdelgawad, M. A., Labib, M. B., & Abdel-Latif, M. (2017). Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1, 2/5-LOX inhibition and docking study. Bioorg Chem, 74, 212-220.
[14] Obasi, L. N., Kaior, G. U., Rhyman, L., Alswaidan, I. A., Fun, H. K., & Ramasami, P. (2016). Synthesis, characterization, antimicrobial screening and computational studies of 4-[3-(4-methoxy-phenyl)-allylideneamino]-1, 5-dimethyl-2-phenyl-1, 2-dihydro-pyrazol-3-one. J. Mol. Struct., 1120, 180-186.
[15] Mondal, S., Pakhira, B., Blake, A. J., Drew, M. G. B., Chattopadhyay, Sh. K. (2016). Co(III) and Ni(II) complexes of an anthracene appended aroyl hydrazone: Synthesis, crystal structures, DNA binding and catecholase activity, Polyhedron, 117, 327-337.
[16] Qin, J., Zhao, S.S., Liu, Y.P., Man, Z.W., Wang, P., Wang, L.N., Xu, Y. and Zhu, H.L., (2016). Preparations, characterization, and biological features of mononuclear Cu (II) complexes based on hydrazone ligands. Bioorg Med Chem Lett, 26(20), 4925-4929.
[17] Xu, G., Tang, B., Gu, L., Zhou, P., & Li, H. (2016). Open coordination sites-induced structural diversity of a new series of Cu (II) complexes with tridentate aroylhydrazone Schiff base. J. Mol. Struct., 1120, 205-214.
[18] Meshram, U. P., Pethe, G. B., Yaul, A. R., Khobragade, B. G., & Narwade, M. L. (2017). Studies in stability constants of schiff base hydrazone complexes with transition metal ions. Effect of ligand on seed germination. Russ. J. Phys. Chem. A, 91, 1877-1882.
[19] Yousif, E. I., Ahmed, R. M., Hasan, H. A., Al-Fahdawi, A. S., & Al-Jeboori, M. J. (2017). Metal complexes of heterocyclic hydrazone Schiff-bases: preparation, spectral characterisation and biological study. Iran. J. Sci. Technol. Trans. A: Sci., 41, 103-109.
[20] Begum, A.B., Rekha, N.D., Kumar, B.V., Ranganatha, V.L. and Khanum, S.A., (2014). Synthesis, characterization, biological and catalytic applications of transition metal complexes derived from Schiff base. Bioorg. Med. Chem. Lett., 24(15), 3559-3564.
[21] Raman, N. and Mahalakshmi, R., (2014). Bio active mixed ligand complexes of Cu (II), Ni (II) and Zn (II): Synthesis, spectral, XRD, DNA binding and cleavage properties. Inorg. Chem. Commun., 40, 157-163.
[22] Zhang, Y., Zhang, L., Liu, L., Guo, J., Wu, D., Xu, G., ... & Jia, D. (2010). Anticancer activity, structure, and theoretical calculation of N-(1-phenyl-3-methyl-4-propyl-pyrazolone-5)-salicylidene hydrazone and its copper (II) complex. Inorganica Chim. Acta, 363(2), 289-293.
[23] Deng, J., Chen, W., & Deng, H. (2016). Synthesis of dipyridyl ketone isonicotinoyl hydrazone copper (II) complex: structure, anticancer activity and anticancer mechanism. J. Fluoresc., 26, 1987-1996.
[24] Shen, S., Chen, H., Zhu, T., Ma, X., Xu, J., Zhu, W., Chen, R., Xie, J., Ma, T., Jia, L. and Wang, Y., (2017). Synthesis, characterization and anticancer activities of transition metal complexes with a nicotinohydrazone ligand. Oncol. Lett., 13(5), 3169-3176.
[25] Du, Y., Chen, W., Fu, X., Deng, H., & Deng, J. (2016). Synthesis and biological evaluation of heterocyclic hydrazone transition metal complexes as potential anticancer agents. RSC advances, 6(111), 109718-109725.
[26] El-Behery, M. and El-Twigry, H. (2007) Synthesis, magnetic, spectral, and antimicrobial studies of Cu(II), Ni(II) Co(II), Fe(III), and UO2(II) complexes of a new Schiff base hydrazone derived from 7-chloro-4-hydrazinoquinoline. Spectrochimica Acta A, 66, 28-36.
[27] Fekri, R., Salehi, M., Asadi, A., & Kubicki, M. (2017). DNA/BSA interaction, bio-activity, molecular docking simulation study and electrochemical properties of hydrazone Schiff base derived Cu (II)/Ni (II) metal complexes: Influence of the nuclearity and metal ions. Polyhedron, 128, 175-187.
[28] Martinez-Fleites,C., Smith, N.L., Turkenburg, J. P., Black, G. W., Taylor, E. J. (2009). Structures of two truncated phage-tail hyaluronate lyases from Streptococcus pyogenes serotype M1, Acta Cryst. F65, 963-966.
[29] Fekri, R., Salehi, M., Asadi, A., & Kubicki, M. (2018). Spectroscopic studies, structural characterization and electrochemical studies of two cobalt (III) complexes with tridentate hydrazone Schiff base ligands: Evaluation of antibacterial activities, DNA‐binding, BSA interaction and molecular docking. Appl. Organomet. Chem., 32(2), e4019.
[30] You, Z.-L., & Zhu, H.-L. (2004). Bis(μ-2-amino pyridine) bis [(trifluoroacetato) silver (I)]. Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 60(10), m517–m519.
[31] Fekri, R., Salehi, M., Asadi, A., & Kubicki, M. (2019). Synthesis, characterization, anticancer and antibacterial evaluation of Schiff base ligands derived from hydrazone and their transition metal complexes. Inorganica Chim. Acta, 484, 245-254.
[32] Parvarinezhad, S., Salehi, M., Kubicki, M., & Eshaghi Malekshah, R. (2022). Experimental and theoretical studies of new Co (III) complexes of hydrazide derivatives proposed as multi‐target inhibitors of SARS‐CoV‐2. Appl. Organomet. Chem., 36(10), e6836.
[33] Wang, X.Y., Cao, G.B. and Yang, T. (2008). (E)-N′-(3, 5-Dibromo-2-hydroxy benzylidene) -4-hydroxy benzohydrazide monohydrate. Acta Crystallogr. E: Structure Reports Online., 64(10), o2022-o2022.
[34] Ayyannan, G., Veerasamy, P., Mohanraj, M., Raja, G., Manimaran, A., Velusamy, M., Bhuvanesh, N., Nandhakumar, R. and Jayabalakrishnan, C. (2017). Biological evaluation of organometallic palladium(II) complexes containing 4‐hydroxybenzoic acid (3‐ethoxy‐2‐hydroxy benzylidene) hydrazide: Synthesis, structure, DNA/protein binding, antioxidant activity and cytotoxicity. Appl. Organomet. Chem., 31(5), e3599.
[35] Ouennoughi, Y., Eddine Karce, H., Aggoun, D., Lanez, T., Ruiz-Rosas, R., Bouzerafa, B., Ourari, A., Morallon, E., (2017). A novel ferrocenic copper(II) complex Salen-like, derived from 5-chloromethyl-2-hydroxyacetophenone and N ferrocenmethylaniline: Design, spectral approach and solvent effect towards electrochemical behavior of Fc+/Fc redox couple, J. Organ. Chem., 848, 344-351.
[36] Deilami, A.B., Salehi, M., Arab, A. & Amiri, A., (2018). Synthesis, crystal structure, electrochemical properties and DFT calculations of three new Zn(II), Ni(II) and Co(III) complexes based on 5-bromo-2-((allylimino)methyl) phenol Schiff-based ligand. Inorganica Chim. Acta, 476, 93-100.
[37] Gholivand, K., Barzegari, A., Yousefian, M., Malekshah, R.E., & Faraghi, M., (2023). Experimental and theoretical evaluation of biological properties of a phosphoramide functionalized graphene oxide Biocatal. Agric. Biotechnol, 47, 102612.
[38] Gholivand, K., Sabaghian, M., & Malekshah, R. E., (2021). Synthesis, characterization, cytotoxicity studies, theoretical approach of adsorptive removal and molecular calculations of four new phosphoramide derivatives and related graphene oxide. Bioorg. Chem., 115, 105193.
[39] Ramezanipoor, S., Parvarinezhad, S., Salehi, M., Grześkiewicz, A. M., & Kubicki, M., (2022). Crystal structures, electrochemical properties and theoretical studies of three New Zn(II), Mn(III) and Co(III) Schiff base complexes derived from 2-hydroxy-1-allyliminomethyl-naphthalen. J. Mol. Struct., 1257, 132541.
[40] Sepehrfar, S., Salehi, M., Parvarinezhad, S., Grześkiewicz, A.M., & Kubicki, M., (2023). New Cu(II), Mn(II) and Mn(III) Schiff base complexes cause noncovalent interactions: X-ray crystallography survey, Hirshfeld surface analysis and molecular simulation investigation against SARS-CoV-2. J. Mol. Struct., 1278, 134857.
[41] Arjun, H.A., Rajan, R.K., Elancheran, R., Ramanathan, M., Bhattacharjee, A. and Kabilan, S. (2020). Crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies on benzohydrazide derivatives as potential inhibitors of prostate cancer. Chem. Data Collect., 26, 100350.
[42] Kanmazalp, S.D., Dege, N., Ilhan, I.O. and Akin, N. (2020). Crystal Structure and Hirshfeld Surface Analysis of 3, 5-Bis (4-Methoxyphenyl)-4, 5-Dihydro-1 H-Pyrazole-1-Carbothioamide. J. Struct. Chem., 61(1), 126-132.
[43] Akkurt, M., Duruskari, G.S., Toze, F.A., Khalilov, A.N. and Huseynova, A.T. (2018). Crystal structure and Hirshfeld surface analysis of (E)-3-[(2, 3-dichlorobenzylidene) amino]-5-phenylthiazolidin-2-iminium bromide. Acta Crystallogr. E: Crystallogr. Commun., 74(8), 1168-1172.
[44] Parvarinezhad, S., Salehi, Kubicki, M., & Eshaghi Malekshah, R., (2022). Synthesis, characterization, spectral studies and evaluation of noncovalent interactions in co-crystal of μ-oxobridged polymeric copper(II) complex derived from pyrazolone by theoretical studies. J. Mol. Struct., 1260,132780.
[45] Parvarinezhad, S., Salehi, M., Eshaghi Malekshah, R., Kubicki, M., & Khaleghian, A., (2022). Synthesis, characterization, spectral studies two new transition metal complexes derived from pyrazolone by theoretical studies, and investigate anti-proliferative activity. Appl. Organomet. Chem., 36(3), e6563.
[46] Ghasemi, L., Behzad, M., Gharib, A., Arab, A., & Abbasi, A., (2023). A pyrazolone-based dinuclear Cu(II) Schiff-base complex: DFT studies on the rate-determining steps of the tautomerism in the ligand and molecular docking modelling with COVID-19 main protease (6LU7). J. Coord. Chem., 76(5-6), 830-846.
[47] Parvarinezhad, S., Salehi, M., Kubicki, M., & Khaleghian A., (2021). Unprecedented formation of a μ-oxobridged dimeric copper (II) complex: Evaluation of structural, spectroscopic, and electronic properties by using theoretical studies and investigations biological activity studies of new Schiff bases derived from pyrazolone. Appl. Organomet. Chem., 35(12), e6443.
[48] Ghasemi, L., Abedi, A., Abbasi, A., Kucerakova, M., Dusek, M., Behzad, M. (2024). Subtle structural variations in new mixed-ligand Cu(II) complexes with NN'O type unsymmetrical Schiff bases: Molecular docking against SARS-Cov-2 and its Omicron variant main proteases, Inorg. Chem. Commun.159, 111795.
